Foghorn Therapeutics Inc. banner

Foghorn Therapeutics Inc.
NASDAQ:FHTX

Watchlist Manager
Foghorn Therapeutics Inc. Logo
Foghorn Therapeutics Inc.
NASDAQ:FHTX
Watchlist
Price: 3.82 USD 0.79% Market Closed
Market Cap: $224.2m

Wall St Price Targets

FHTX Price Targets Summary
Foghorn Therapeutics Inc.

Wall Street analysts forecast FHTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FHTX is 11.35 USD with a low forecast of 9.09 USD and a high forecast of 13.65 USD.

Lowest Forecast
Price Target
9.09 USD
138% Upside
Average Forecast
Price Target
11.35 USD
197% Upside
Highest Forecast
Price Target
13.65 USD
257% Upside
Foghorn Therapeutics Inc. Competitors:
Price Targets
VINP
Vinci Partners Investments Ltd
40% Upside
NSIT
Insight Enterprises Inc
15% Upside
1981
Cathay Media and Education Group Inc
37% Upside
BTBT
Bit Digital Inc
204% Upside
SSRM
SSR Mining Inc
48% Upside
PTGX
Protagonist Therapeutics Inc
19% Upside

Revenue
Forecast

N/A
Past Growth
39% / Year
Estimated Growth
Estimates Accuracy
-23%
Average Miss
N/A
Past Growth
39% / Year
Estimated Growth
Estimates Accuracy
-23%
Average Miss

The compound annual growth rate for Revenue over the next 8 years is 39%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-28%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-28%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is FHTX's stock price target?
Price Target
11.35 USD

According to Wall Street analysts, the average 1-year price target for FHTX is 11.35 USD with a low forecast of 9.09 USD and a high forecast of 13.65 USD.

What is the Revenue forecast for Foghorn Therapeutics Inc.?
Projected CAGR
39%

The compound annual growth rate for Revenue over the next 8 years is 39%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett